Dapagliflozin 10mg + Metformin 1000mg Tablets in PCD pharma franchise in Hyderabad

Dapagliflozin 10mg + Metformin 1000mg Tablets in pharmaceutical manufacturing company in Mumbai

Dapagliflozin 10mg + Metformin 1000mg Tablets in diabetic pharma franchise in Pune

Dapagliflozin 10mg + Metformin 1000mg Tablets in pharma suppliers in Delhi

Dapagliflozin 10mg + Metformin 1000mg Tablets in pharma export companies in Kolkata
Dapagliflozin 10mg + Metformin 1000mg Tablets in pharma franchise opportunities in Bengaluru

Dapoflit M Forte

Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 1000mg Tablets

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Please Contact For Best Price

Dapoflit M Forte Tablet is a dual-action oral antidiabetic medication combining Dapagliflozin (10mg), a selective SGLT2 inhibitor, with Metformin Hydrochloride (1000mg), a biguanide class agent. This combination helps improve glycemic control in adults with Type 2 Diabetes Mellitus (T2DM) by promoting urinary glucose excretion and reducing hepatic glucose production. The formulation works synergistically to lower blood glucose levels, support weight management, and reduce insulin resistance.

Read More

About the Product

Dapoflit M Forte Tablet is a dual-action oral antidiabetic medication combining Dapagliflozin (10mg), a selective SGLT2 inhibitor, with Metformin Hydrochloride (1000mg), a biguanide class agent. This combination helps improve glycemic control in adults with Type 2 Diabetes Mellitus (T2DM) by promoting urinary glucose excretion and reducing hepatic glucose production. The formulation works synergistically to lower blood glucose levels, support weight management, and reduce insulin resistance.

Common side effects include urinary tract infections, genital mycotic infections, nausea, diarrhea, and increased urination. In rare cases, lactic acidosis (with metformin) or ketoacidosis (with dapagliflozin) may occur. Dehydration and hypotension may be observed in volume-depleted individuals.

Dapoflit M Forte is indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 Diabetes Mellitus, particularly in patients who require dual therapy for adequate blood sugar control. It may also be considered for those at risk of cardiovascular complications associated with diabetes.

Use under medical supervision only. Not recommended in patients with severe renal impairment or active bladder cancer. Monitor renal function and blood glucose regularly. Discontinue temporarily during acute illness, surgery, or dehydration risk to minimize lactic acidosis risk from metformin.

Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep out of reach of children.

Get in Touch